202 related articles for article (PubMed ID: 35065983)
21. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.
Gomez-Rubio P; Rosato V; Márquez M; Bosetti C; Molina-Montes E; Rava M; Piñero J; Michalski CW; Farré A; Molero X; Löhr M; Ilzarbe L; Perea J; Greenhalf W; O'Rorke M; Tardón A; Gress T; Barberá VM; Crnogorac-Jurcevic T; Muñoz-Bellvís L; Domínguez-Muñoz E; Gutiérrez-Sacristán A; Balsells J; Costello E; Guillén-Ponce C; Huang J; Iglesias M; Kleeff J; Kong B; Mora J; Murray L; O'Driscoll D; Peláez P; Poves I; Lawlor RT; Carrato A; Hidalgo M; Scarpa A; Sharp L; Furlong LI; Real FX; La Vecchia C; Malats N;
Ann Oncol; 2017 Jul; 28(7):1618-1624. PubMed ID: 28383714
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival.
Petrusel L; Bilibou M; Drug V; Leucuta DC; Seicean R; Cainap C; Seicean A
J Gastrointestin Liver Dis; 2020 Sep; 29(3):391-398. PubMed ID: 32919422
[TBL] [Abstract][Full Text] [Related]
23. Impact of genetic variants of ABCB1, APOB, CAV1, and NAMPT on susceptibility to pancreatic ductal adenocarcinoma in Chinese patients.
Li B; Zhang C; Wang J; Zhang M; Liu C; Chen Z
Mol Genet Genomic Med; 2020 Jun; 8(6):e1226. PubMed ID: 32243098
[TBL] [Abstract][Full Text] [Related]
24. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
He XY; Li JF; Yao WY; Yuan YZ
Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
[TBL] [Abstract][Full Text] [Related]
25. Elevated Glycated Haemoglobin (HbA1c) Is Associated with an Increased Risk of Pancreatic Ductal Adenocarcinoma: A UK Biobank Cohort Study.
McDonnell D; Cheang AWE; Wilding S; Wild SH; Frampton AE; Byrne CD; Hamady ZZ
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627106
[TBL] [Abstract][Full Text] [Related]
26. Genetic and non-genetic risk factors for early-onset pancreatic cancer.
Nodari Y; Gentiluomo M; Mohelnikova-Duchonova B; Kreivenaite E; Milanetto AC; Skieceviciene J; Landi S; Lawlor RT; Petrone MC; Arcidiacono PG; Lovecek M; Gazouli M; Bijlsma MF; Morelli L; Kiudelis V; Tacelli M; Zanette DL; Soucek P; Uzunoglu F; Kaaks R; Izbicki J; Boggi U; Pezzilli R; Mambrini A; Pasquali C; van Laarhoven HW; Katzke V; Cavestro GM; Sperti C; Loos M; Latiano A; Erőss B; Oliverius M; Johnson T; Basso D; Neoptolemos JP; Aoki MN; Greenhalf W; Vodicka P; Archibugi L; Vanella G; Lucchesi M; Talar-Wojnarowska R; Jamroziak K; Saeedi MA; van Eijck CHJ; Kupcinskas J; Hussein T; Puzzono M; Bunduc S; Götz M; Carrara S; Szentesi A; Tavano F; Moz S; Hegyi P; Luchini C; Capurso G; Perri F; Ermini S; Theodoropoulos G; Capretti G; Palmieri O; Ginocchi L; Furbetta N; Canzian F; Campa D
Dig Liver Dis; 2023 Oct; 55(10):1417-1425. PubMed ID: 36973108
[TBL] [Abstract][Full Text] [Related]
27. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
Yu S; Li Y; Liao Z; Wang Z; Wang Z; Li Y; Qian L; Zhao J; Zong H; Kang B; Zou WB; Chen K; He X; Meng Z; Chen Z; Huang S; Wang P
Gut; 2020 Mar; 69(3):540-550. PubMed ID: 31562239
[TBL] [Abstract][Full Text] [Related]
28. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
[TBL] [Abstract][Full Text] [Related]
29. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
Nesteruk K; Levink IJM; de Vries E; Visser IJ; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
Pancreatology; 2022 Jun; 22(5):626-635. PubMed ID: 35613957
[TBL] [Abstract][Full Text] [Related]
30. Incidence and Risk of Pancreatic Cancer in Patients with a New Diagnosis of Chronic Pancreatitis.
Munigala S; Subramaniam DS; Subramaniam DP; Burroughs TE; Conwell DL; Sheth SG
Dig Dis Sci; 2022 Feb; 67(2):708-715. PubMed ID: 33630214
[TBL] [Abstract][Full Text] [Related]
31. Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes.
Oldfield L; Evans A; Rao RG; Jenkinson C; Purewal T; Psarelli EE; Menon U; Timms JF; Pereira SP; Ghaneh P; Greenhalf W; Halloran C; Costello E
EBioMedicine; 2022 Jan; 75():103802. PubMed ID: 34990893
[TBL] [Abstract][Full Text] [Related]
32. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.
Andersen DK; Andren-Sandberg Å; Duell EJ; Goggins M; Korc M; Petersen GM; Smith JP; Whitcomb DC
Pancreas; 2013 Nov; 42(8):1227-37. PubMed ID: 24152948
[TBL] [Abstract][Full Text] [Related]
33. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
[TBL] [Abstract][Full Text] [Related]
34. The Role of Insulin-like Growth Factor (IGF) Axis in Early Diagnosis of Pancreatic Adenocarcinoma (PDAC).
Wlodarczyk B; Gasiorowska A; Malecka-Panas E
J Clin Gastroenterol; 2018 Aug; 52(7):569-572. PubMed ID: 29912760
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study.
Capurso G; Boccia S; Salvia R; Del Chiaro M; Frulloni L; Arcidiacono PG; Zerbi A; Manta R; Fabbri C; Ventrucci M; Tarantino I; Piciucchi M; Carnuccio A; Boggi U; Leoncini E; Costamagna G; Delle Fave G; Pezzilli R; Bassi C; Larghi A; ;
Am J Gastroenterol; 2013 Jun; 108(6):1003-9. PubMed ID: 23458848
[TBL] [Abstract][Full Text] [Related]
36. Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes.
Balasenthil S; Liu S; Dai J; Bamlet WR; Petersen G; Chari ST; Maitra A; Chen N; Sen S; McNeill Killary A
Clin Chim Acta; 2023 Nov; 551():117567. PubMed ID: 37774897
[TBL] [Abstract][Full Text] [Related]
37. Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
Huntley C; Torr B; Sud A; Rowlands CF; Way R; Snape K; Hanson H; Swanton C; Broggio J; Lucassen A; McCartney M; Houlston RS; Hingorani AD; Jones ME; Turnbull C
Lancet Oncol; 2023 Jun; 24(6):658-668. PubMed ID: 37178708
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of metabolic pathways could offset the poor prognosis conferred by co-existent diabetes mellitus in pancreatic (head) adenocarcinoma.
Gardi N; Ketkar M; McKinnon RA; Pandol SJ; Dutt S; Barreto SG
ANZ J Surg; 2021 Nov; 91(11):2466-2474. PubMed ID: 34514690
[TBL] [Abstract][Full Text] [Related]
39. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.
Choi JH; Lee SH; Huh G; Chun JW; You MS; Paik WH; Ryu JK; Kim YT
Cancer Med; 2019 Dec; 8(17):7419-7430. PubMed ID: 31637875
[TBL] [Abstract][Full Text] [Related]
40. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
